Centre of Microbial and Plant Genetics, KU Leuven, Leuven, Belgium.
VIB Center for Microbiology, Flanders Institute for Biotechnology, Leuven, Belgium.
ISME J. 2019 May;13(5):1239-1251. doi: 10.1038/s41396-019-0344-9. Epub 2019 Jan 15.
Persisters are transiently antibiotic-tolerant cells that complicate the treatment of bacterial infections. Both theory and experiments have suggested that persisters facilitate genetic resistance by constituting an evolutionary reservoir of viable cells. Here, we provide evidence for a strong positive correlation between persistence and the likelihood to become genetically resistant in natural and lab strains of E. coli. This correlation can be partly attributed to the increased availability of viable cells associated with persistence. However, our data additionally show that persistence is pleiotropically linked with mutation rates. Our theoretical model further demonstrates that increased survival and mutation rates jointly affect the likelihood of evolving clinical resistance. Overall, these results suggest that the battle against antibiotic resistance will benefit from incorporating anti-persister therapies.
持留菌是暂时具有抗生素耐药性的细胞,这使得细菌感染的治疗变得复杂。理论和实验都表明,持留菌通过构成有活力细胞的进化储备,促进了遗传耐药性的形成。在这里,我们提供了证据表明,在大肠杆菌的自然和实验室菌株中,持留菌与遗传耐药性的可能性之间存在强烈的正相关。这种相关性部分归因于与持留菌相关的有活力细胞的可用性增加。然而,我们的数据还表明,持留菌与突变率存在多效性联系。我们的理论模型进一步表明,存活和突变率的增加共同影响了进化出临床耐药性的可能性。总的来说,这些结果表明,对抗抗生素耐药性的斗争将受益于引入抗持留菌疗法。